• Wed, February 12, 2025

by: Investopedia

Tesla, Palantir Among Top Gainers Today With Stocks Under Pressure

Before joining Investopedia, David Marino-Nachison was an editor at The Wall Street Journal focused mainly on daily markets and investing news. He also worked on The Journal's publishing desk; as a writer and editor covering stocks at Barron's ...

by: WOPRAI

Short squeeze is starting in shares of WHG at $16.1, after crossing above the $15.794 Trigger Price

by: MarketWatch

Stock Market Today: Dow ends about 225 points lower, S&P 500 and Nasdaq fall after hot CPI report; Robinhood and Reddit earnings on deck

The strong CPI print for January is raising concerns about a reacceleration in inflation, along with questions about whether the Fed could keep interest rates on hold for the rest of 2025.

by: Forbes

5 Keys To Investing Like A Happy Retiree And Retiring Sooner

Happy retirees know that by investing for tomorrow, potentially with stock dividends, today doesn't have to be perfect.

by: FXStreet

Is Tesla stock headed for $270?

It's only Tuesday, and yet Tesla (TSLA) stock is already down 9.2% this week. In fact, if you include Friday, in just the last three sessions TSLA shares have given up 12.2% or $147 billion in market cap.

by: Indiatimes

Best focused mutual funds to invest in February 2025

by: MSN

Q3 as per expectation, no big negative surprise; investing in pvt banks: Sandip Agarwal

Sandip Agarwal, Co-Founder of Sowilo Investment Managers, highlights their strong investment in private banks due to optimistic GDP forecasts and the anticipated Rs 1 lakh crore tax relief. He explains that recent market corrections brought sanity to stock prices and expects credit growth.

by: MSN

2 high-quality ASX 200 blue chip shares to buy and hold in February

Analysts are expecting great returns from these buy-rated blue chips. The post 2 high-quality ASX 200 blue chip shares to buy and hold in February appeared first on The Motley Fool Australia.

by: WOPRAI

Short squeeze is starting in shares of JAZZ at $134.715, after crossing above the $134.54 Trigger Price

by: MSN

Up 135% in a year, why this ASX 200 healthcare stock is 'on track to become a truly great Australian success'

A leading fund manager expects more strong performance from this surging ASX 200 healthcare stock. The post Up 135% in a year, why this ASX 200 healthcare stock is 'on track to become a truly great Australian success' appeared first on The Motley Fool Australia.

by: WOPRAI

Short squeeze is starting in shares of AOUT at $16.705, after crossing above the $16.664 Trigger Price

by: WOPRAI

Short squeeze is starting in shares of CLDI at $1.455, after crossing above the $1.442 Trigger Price

by: MSN

Lam Research (LRCX) - $1.2 Billion Bet on India's Semiconductor Future!

We recently published a list of 10 AI Stocks Analysts Are Watching: Latest Ratings and News. In this article, we are going to take a look at where Lam Research Corporation (NASDAQ:LRCX) stands against other AI stocks analysts are watching.

by: MSN

Own ANZ shares? Here's what to watch in next week's report

What will be included in next week's quarterly update? The post Own ANZ shares? Here's what to watch in next week's report appeared first on The Motley Fool Australia.

by: WOPRAI

Short squeeze is starting in shares of SVT at $10.95, after crossing above the $10.947 Trigger Price

by: WOPRAI

Short squeeze is starting in shares of JAGX at $0.823, after crossing above the $0.821 Trigger Price

by: MSN

Investing in the Stock Market vs. Saving in the Bank: What's Best for You?

Understanding the nuances between saving and investing is crucial for financial growth. While saving offers security, investing can provide higher returns. Explore the risks and rewards of each to make informed decisions about your financial future.

by: MSN

Is the iShares S&P 500 ETF (IVV) still a brilliant buy after storming higher?

Should investors still buy this fund or is it too expensive? The post Is the iShares S&P 500 ETF (IVV) still a brilliant buy after storming higher? appeared first on The Motley Fool Australia.

by: WOPRAI

Short squeeze is starting in shares of EH at $25.42, after crossing above the $25.266 Trigger Price

by: WOPRAI

Short squeeze is starting in shares of RHHBY at $40.17, after crossing above the $40.131 Trigger Price

by: MSN

General Mills, Inc. (GIS): Jim Cramer on Why "People Will Always Eat Cereal"

We recently published a list of 17 Best Stocks for Kids According to Jim Cramer. In this article, we are going to take a look at where General Mills, Inc. (NYSE:GIS) stands against other best stocks for kids according to Jim Cramer.

by: WOPRAI

Short squeeze is starting in shares of SIDU at $2.8, after crossing above the $2.791 Trigger Price

by: MSN

5 things to watch on the ASX 200 on Thursday

Here's what to expect on the local market today. The post 5 things to watch on the ASX 200 on Thursday appeared first on The Motley Fool Australia.

by: MSN

Alibaba, Tesla Lead Wednesday's Market Cap Stock Movers

Wednesday's market has seen significant movements in various stocks, with some notable fluctuations in the mega-cap and large-cap categories. Alibaba-exch and Tesla Motors (NASDAQ:TSLA) are among the companies experiencing substantial intra-day stock movements,

by: WOPRAI

Short squeeze is starting in shares of CCCS at $10.965, after crossing above the $10.946 Trigger Price

by: MSN

Chevron plans to lay off up to 20% of workers as part of cost-cutting measures - Barron's

Chevron (NYSE:CVX) told employees on Wednesday that it is planning to lay off between 15% and 20% of its workforce, which is approximately 6,000 to 8,000, as reported by Barron's. The company's Vice Chairman,

by: WOPRAI

Short squeeze is starting in shares of TMQ at $1.27, after crossing above the $1.268 Trigger Price

by: WOPRAI

Short squeeze is starting in shares of LSCC at $59.615, after crossing above the $59.26 Trigger Price

by: MSN

Johnson & Johnson (JNJ): Jim Cramer on "The Greatest Health Care Stock of All Time"

We recently published a list of 17 Best Stocks for Kids According to Jim Cramer. In this article, we are going to take a look at where Johnson & Johnson (NYSE:JNJ) stands against other best stocks for kids according to Jim Cramer.

by: WOPRAI

Short squeeze is starting in shares of BKD at $4.925, after crossing above the $4.921 Trigger Price

  • Thu, February 13, 2025

by: Mint

Five Indian stocks that could benefit from Trump's tariffs on China

With a 10% tariff making Chinese products costlier, US importers may turn to Indian companies as cost-effective alternatives. Here are five Indian stocks that could benefit from this shift.

by: Moneyweb

Alternative investments? Understand the risks first

History has shown that poorly structured alternative investments can lead to disastrous financial outcomes for unsuspecting investors.

by: MSN

Robinhood surges 15% after a blockbuster quarter. The CEO says it's now a place for 'people's serious money.'

The company said it finished the fourth quarter with $1.3 billion in net transfers, more than any other brokerage.

by: MSN

ASX 200 strikes new record high

Chemist Warehouse shares are soaring today. The post ASX 200 strikes new record high appeared first on The Motley Fool Australia.

by: MSN

I'm the fund manager of Temple Bar Investment Trust: Here's where I would invest now

Ian Lance, co-fund manager, Temple Bar Investment Trust shares his thoughts on on Pearson, Nvidia, Bitcoin and the 'cheap' UK market.

by: MSN

Alphabet Inc. (GOOGL): Jim Cramer on Google's Advertising Powerhouse

We recently published a list of 17 Best Stocks for Kids According to Jim Cramer. In this article, we are going to take a look at where Alphabet Inc. (NASDAQ:GOOGL) stands against other best stocks for kids according to Jim Cramer.

by: WOPRAI

As of Feb 13th, 2025, there has been substantial selling of Patriot National Bancorp, Inc. in recent trading

by: WOPRAI

As of Feb 13th, 2025, there has been substantial selling of DigiAsia Corp. in recent trading

by: WOPRAI

As of Feb 13th, 2025, there has been substantial selling of GoldHaven Resources Corp. in recent trading

by: WOPRAI

As of Feb 13th, 2025, there has been substantial selling of Windtree Therapeutics, Inc. in recent trading

by: WOPRAI

As of Feb 13th, 2025, there has been substantial selling of Denny's Corporation in recent trading

by: WOPRAI

As of Feb 13th, 2025, there has been substantial selling of Silver Bull Resources, Inc. in recent trading

by: WOPRAI

As of Feb 13th, 2025, there has been substantial selling of Adia Nutrition, Inc. in recent trading

by: WOPRAI

As of Feb 13th, 2025, there has been substantial selling of Oatly Group AB in recent trading

by: WOPRAI

As of Feb 13th, 2025, there has been substantial selling of Mission West Properties Inc. in recent trading

by: WOPRAI

As of Feb 13th, 2025, there has been substantial selling of Vynleads, Inc. in recent trading

by: WOPRAI

As of Feb 13th, 2025, there has been substantial selling of The Alkaline Water Company Inc. in recent trading

by: WOPRAI

As of Feb 13th, 2025, there has been substantial selling of in recent trading

Johnson & Johnson (JNJ): Jim Cramer on "The Greatest Health Care Stock of All Time"

We recently published a list of 17 Best Stocks for Kids According to Jim Cramer. In this article, we are going to take a look at where Johnson & Johnson (NYSE:JNJ) stands against other best stocks for kids according to Jim Cramer.
The article from MSN Money discusses Jim Cramer's perspective on Johnson & Johnson (J&J), which he describes as "the greatest health care stock of all time." Cramer highlights J&J's diversified business model, which spans pharmaceuticals, medical devices, and consumer health products, providing stability and growth. He points out that despite facing numerous lawsuits, particularly related to its talc products, J&J has managed to maintain its reputation and financial health through strategic decisions like spinning off its consumer health business into a new entity named Kenvue. This move, according to Cramer, allows J&J to focus more on its high-margin pharmaceutical and medical technology sectors. He also praises the company's consistent dividend increases, making it a favorite among investors looking for reliable income. Furthermore, Cramer notes J&J's robust pipeline of new drugs and its ability to innovate, which underpins his confidence in the stock's long-term value.

Read the Full MSN Article at:
https://www.msn.com/en-us/money/other/johnson-johnson-jnj-jim-cramer-on-the-greatest-health-care-stock-of-all-time/ar-AA1yUzzV

Like: 👍